In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices...more
6/16/2020
/ Biotechnology ,
Collaboration ,
Commercial Contracts ,
Commercially Reasonable Efforts ,
Contract Terms ,
Coronavirus/COVID-19 ,
Force Majeure Clause ,
License Agreements ,
Life Sciences ,
Performance Standards ,
Pharmaceutical Industry
The outbreak of coronavirus (also known as COVID-19) is reportedly impacting global manufacturing, transportation and cross-border supply chains underpinning many aspects of international trade and commerce. Some companies...more
2/26/2020
/ Breach of Contract ,
Commercial Contracts ,
Commercial General Liability Policies ,
Contract Terms ,
Coronavirus/COVID-19 ,
Financial Contracts ,
Force Majeure Clause ,
Frustration of a Common Purpose ,
Global Economy ,
Infectious Diseases ,
Manufacturers ,
Material Adverse Effects ,
Nonperformance ,
Notice Requirements ,
Supply Chain ,
Transportation Industry
On December 5, 2018, Skadden hosted the webinar “Drafting International Dispute Resolution Clauses.” Topics included the importance of dispute resolution clauses, choosing between litigation and arbitration, drafting...more
1/21/2019
/ Arbitration Agreements ,
Best Practices ,
Confidential Communications ,
Contract Drafting ,
Contract Terms ,
Discovery ,
Dispute Resolution ,
Expert Witness ,
Forum Non Conveniens ,
International Arbitration ,
International Litigation ,
Jurisdiction ,
Litigation Strategies ,
Multi-Party Litigation ,
Non-Appealable Decisions ,
Pleading Standards ,
Question of Arbitrability ,
Service of Process ,
Venue